Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03999983 · ClinicalTrials.gov registry record
Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
A clinical trial of Vertebral Artery Stenosis, sponsored by St. Louis University.
- Recruiting
- Registry status
- 150
- Enrollment target
- 10
- Study locations
NCT03999983: Recruiting study of Vertebral Artery Stenosis, sponsored by St. Louis University.
NCT03999983 is a study of Vertebral Artery Stenosis that is actively recruiting participants, run by St. Louis University. The registered enrollment target is 150 participants. The trial reports 10 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03999983, a study of Vertebral Artery Stenosis, is actively recruiting participants, sponsored by St. Louis University.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 10
- Study locations
Study Summary
A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).
Primary Outcome
Recurrent stroke of any type or death from any cause
Conditions Studied
Interventions
- OTHER Observational Prospective Registry
Study Locations (10)
Florida
- Baptist Medical Center Jacksonville - Jacksonville
- University of Southern Florida - Tampa
Missouri
- SSM DePaul Hospital - Bridgeton
- Saint Louis University - St Louis
Ohio
- Cleveland Clinic - Cleveland
- Mercy Health Neuroscience Institute - Toledo
Illinois
- Northwestern Medicine Regional Medical Group - Winfield
Iowa
- University of Iowa - Iowa City
Tennessee
- Semmes Murphey Clinic - Memphis
Texas
- Texas Tech University Health Science Center of El Paso - El Paso
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-11-19 |
| Est. Completion | 2026-12 |
What NCT03999983 shows while recruiting
NCT03999983 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Vertebral Artery Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Observational Prospective Registry is the first listed.
NCT03999983 lists 10 locations in 7 states (Florida, Missouri, Ohio).
Frequently Asked Questions
What is clinical trial NCT03999983 about?
NCT03999983 is a clinical study titled "Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)". A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).
What is the current status of trial NCT03999983?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2019-11-19. Estimated completion is 2026-12.
What conditions does trial NCT03999983 study?
This clinical trial studies the following conditions: Vertebral Artery Stenosis.
What interventions are being tested in trial NCT03999983?
The interventions under investigation include: Observational Prospective Registry (OTHER).
Who is sponsoring clinical trial NCT03999983?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03999983 being conducted?
This trial has 10 study locations across Florida, Illinois, Iowa, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI